ELEVATE, a Registry of Patients With Acute Hepatic Porphyria (AHP)

RecruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

April 26, 2021

Primary Completion Date

April 1, 2027

Study Completion Date

April 1, 2027

Conditions
Acute Hepatic Porphyria
Trial Locations (29)

10029

RECRUITING

Clinical Trial Site, New York

19107

COMPLETED

Clinical Trial Site, Philadelphia

21205

RECRUITING

Clinical Trial Site, Baltimore

27157

RECRUITING

Clinical Trial Site, Winston-Salem

35233

RECRUITING

Clinical Trial Site, Birmingham

55455

RECRUITING

Clinical Trial Site, Minneapolis

73120

RECRUITING

Clinical Trial Site, Oklahoma City

77555

RECRUITING

Clinical Trial Site, Galveston

84112

RECRUITING

Clinical Trial Site, Salt Lake City

85234

RECRUITING

Clinical Trial Site, Gilbert

90074

RECRUITING

Clinical Trial Site, San Francisco

98195

RECRUITING

Clinical Trial Site, Seattle

02114

RECRUITING

Clinical Trial Site, Boston

Unknown

RECRUITING

Clinical Trial Site, Leuven

RECRUITING

Clinical Trial Site, Bordeaux

RECRUITING

Clinical Trial Site, Paris

RECRUITING

Clinical Trial Site, Toulouse

RECRUITING

Clinical Trial Site, Berlin

RECRUITING

Clinical Trial Site, Chemnitz

RECRUITING

Clinical Trial Site, Würzburg

RECRUITING

Clinical Trial Site, Milan

RECRUITING

Clinical Trial Site, Modena

RECRUITING

Clinical Trial Site, Madrid

RECRUITING

Clinical Trial Site, Stockholm

RECRUITING

Clinical Trial Site, Zurich

RECRUITING

Clinical Trial Site, Taichung

RECRUITING

Clinical Trial Site, Taipei

RECRUITING

Clinical Trial Site, Cardiff

RECRUITING

Clinical Trial Site, London

Sponsors
All Listed Sponsors
lead

Alnylam Pharmaceuticals

INDUSTRY